Pembrolizumab combined with carfilzomib and low‐dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE‐023 study

Detalles Bibliográficos
Autores principales: Moreau, Philippe, Ghori, Razi, Farooqui, Mohammed, Marinello, Patricia, San Miguel, Jesus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Online Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361977/
https://www.ncbi.nlm.nih.gov/pubmed/34114211
http://dx.doi.org/10.1111/bjh.17448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361977/
https://www.ncbi.nlm.nih.gov/pubmed/34114211
http://dx.doi.org/10.1111/bjh.17448

Ejemplares similares